| scholarly article | Q13442814 |
| P50 | author | Hilary Koprowski | Q936389 |
| Charles Edward Rupprecht | Q60394248 | ||
| P2093 | author name string | Hooper DC | |
| Hanlon CA | |||
| Niezgoda M | |||
| Notkins A | |||
| DeMattos CA | |||
| DeMattos CC | |||
| P2860 | cites work | Encephalitis caused by a Lyssavirus in fruit bats in Australia | Q24654775 |
| Development of Orphan Vaccines: An Industry Perspective | Q27487916 | ||
| Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993 and 1994 | Q28755448 | ||
| Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins | Q33783353 | ||
| Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies | Q35814688 | ||
| Human rabies immune globulin | Q36075543 | ||
| Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus | Q36350202 | ||
| Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia. | Q41018471 | ||
| Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis | Q41019444 | ||
| Cell hybridization, hybridomas, and human hybridomas | Q41029482 | ||
| Development of human monoclonal antibodies to rabies | Q41439303 | ||
| A Rabies-Specific Human Monoclonal Antibody That Protects Mice Against Lethal Rabies | Q41662869 | ||
| Incidence of reactions to antirabies horse serum | Q41916316 | ||
| Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein | Q42812165 | ||
| Epidemiology of human rabies in the United States, 1980 to 1996. | Q43214021 | ||
| Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV). | Q44125158 | ||
| The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. | Q45744398 | ||
| Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. | Q45829999 | ||
| Genetically engineered antibodies in gene transfer and gene therapy | Q45889742 | ||
| Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. | Q50643568 | ||
| Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine | Q67379252 | ||
| Failure of rabies postexposure treatment in Thailand | Q69606301 | ||
| Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost | Q71270848 | ||
| Failure of postexposure treatment of rabies in children | Q71608291 | ||
| Partial recovery from rabies in a nine-year-old boy | Q72634821 | ||
| Additional reports of failure to respond to treatment after rabies exposure in Thailand | Q74460219 | ||
| Capture of human monoclonal antibodies from cell culture supernatant by ion exchange media exhibiting high charge density | Q74660693 | ||
| P433 | issue | 28-29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rabies | Q39222 |
| rabies virus | Q698976 | ||
| post-exposure prophylaxis | Q1361206 | ||
| P304 | page(s) | 3834-3842 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis | |
| P478 | volume | 19 |
| Q35317519 | A universal real-time assay for the detection of Lyssaviruses. |
| Q39823763 | Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains |
| Q36055994 | Antibody processing and engineering in plants, and new strategies for vaccine production. |
| Q38722970 | Co-culture: A quick approach for isolation of street rabies virus in murine neuroblastoma cells |
| Q33514828 | Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans |
| Q28601417 | Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis |
| Q33816066 | Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody. |
| Q21144786 | Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs |
| Q30728002 | Function and glycosylation of plant-derived antiviral monoclonal antibody |
| Q40382923 | Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody, #1-46-12. |
| Q34296691 | Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein |
| Q36668132 | Human rabies and its prevention |
| Q40180565 | Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates |
| Q37011499 | Lyssaviruses |
| Q24531953 | Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants |
| Q24520604 | Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis |
| Q38006132 | Passive immunity in the prevention of rabies. |
| Q42240366 | Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein |
| Q35714659 | Rabies and other lyssavirus diseases |
| Q40505899 | Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses |
| Q34764816 | Rabies re-examined |
| Q48402986 | Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines |
| Q90024473 | Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline |
| Q47562878 | SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies |
| Q33217631 | The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries |
| Q36238718 | Vaccines for lyssaviruses other than rabies |
Search more.